helpful info. thank you. shame no one responded directly to your earlier post re toxicology - guess it got lost in the hall of mirrors. i also bought some more today but have some reservations re poss ph manipulation - but perhaps no basis for that.
I do think some of the people on this board have been here a very long time. And that may have a created a certain culture that looks a bit eccentric to outsiders/newbies. But vitriol. yeah, not just here. I try not to do it. Don't always succeed. We could at least try. Thanks for the post. Morning all.
Did anyone else buy into this? Sorry Brazil for stealing your research - it keeps on going up. Reminds me of Palantir - so I'm not selling till it gets a lot higher. And even then I will hang onto 60%.
RE: Psychological £2 barrier/resistance28 Oct 2021 15:57
"200 breached and no retrace."
I had my flu booster shot today and asked the pharmacist if she thought we'd be having covid and flu vaccines for the next couple of years. "Next 20 years," she said. So thats the market.
Yes. I noticed. Haven't had time to read the release in detail. But I think Covid vaccines are not a short-term business (sadly) and hope Valneva will do well. Hopefully have time to read all tomorrow.
I'm off to struggle with the research - its like homework...going through endless pharma papers about inhibitors and oncogenes, I'd so much rather go and see the new Wes Anderson film again - or just spout cr*p about covid and the sp. Thats also easy. Thanks for the guidance people. take care all.
For me the potential re Covid is based on my understanding that Covid - vaccines, masks, social distancing - all that sh*t, is going to be with us, in one form or another, for the next 10-25 years.
If you check Activ 2 - the US govt's program to fast-track Covid therapeutics - the end date for the project to evaluate some potential treatments, as far as I can tell is Dec 31st 2023. See link below. That date tells me there is no rush regarding bringing Covid therapeutics to market. (And I know that SAR is not a Covid play or at least not exclusively) But anyway, that date also suggests something rather bleak regarding Covid and the next few years. But it gives me a very clear message about the market for Covid therapeutics - it may be open for a very very long time. But hey I can just as easily be wrong. Feedback and correction welcome.
Interesting that RNS keeps Agile in the frame. Would like to square this with issue Stach raised re toxicology - but can I presume issues raised by Stach are not insurmountable?
For me the sp's destination is unknown. This is quite exciting. I also need to look at Activ Phase 3 time-line. Have to go on to the US Activ site. All info is there? take care all.